OR WAIT null SECS
December 20, 2022
In this episode of the Drug Solutions Podcast, Meg Rivers discusses outsourcing strategies in biopharma with Jeff Henderson, key account manager of Vetter.
December 07, 2022
In this episode of the Drug Solutions Podcast, Chris Spivey interviews executives at Shabas Solutions LLC, who ran the overseas QMM pilot project.
November 08, 2022
Scorpion’s new facility is designed for the development and manufacturing of clinical and commercial-scale biologic drugs.
November 02, 2022
In this article, the potential pitfalls of technology transfers are discussed as well as ways to ensure a smooth transition.
November 01, 2022
The company is expanding its contract development and manufacturing services for parenteral drugs to global customers.
October 31, 2022
The CPHI Annual Report 2022 predicts cash reserves from venture capitalists and private equities will drive expansion in the demand for contract research organizations and contract development and research organizations.
October 06, 2022
Sponsors should explore key considerations ahead of choosing a new outsourcing partner.
October 02, 2022
Whether biologic manufacturers decide to outsource or develop products internally, the quality of a CDMO partnership is critical to success, especially for cell and gene therapy products.
September 02, 2022
By eliminating the waste involved in traditional approaches to project set-up and execution, integrated project delivery helps innovators in the European life sciences market meet their fast-track delivery targets.
August 23, 2022
The latest CPHI report has been published, predicting that a significant shift in outsourcing strategies is being experienced globally.